Medpace Holdings, Inc. (FRA:01P)

Market Cap	14.39B
Revenue (ttm)	2.01B
Net Income (ttm)	368.98M
Shares Out	n/a
EPS (ttm)	12.20
PE Ratio	39.01
Forward PE	37.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10
Average Volume	11
Open	521.20
Previous Close	520.00
Day's Range	507.60 - 521.20
52-Week Range	227.70 - 558.20
Beta	n/a
RSI	53.13
Earnings Date	Feb 9, 2026

About Medpace Holdings

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigi...

• Industry: Commercial Physical and Biological Research
• Founded: 1992
• Employees: 5,900
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 01P

Financial Performance

In 2024, Medpace Holdings's revenue was $2.11 billion, an increase of 11.84% compared to the previous year's $1.89 billion. Earnings were $404.34 million, an increase of 43.07%.

Financial numbers in USD